448 related articles for article (PubMed ID: 31210170)
21. Lucio's phenomenon: A systematic literature review of definition, clinical features, histopathogenesis and management.
Frade MAC; Coltro PS; Filho FB; Horácio GS; Neto AA; da Silva VZ; Westin AT; Guimarães FR; Innocentini LMAR; Motta ACF; Farina JA
Indian J Dermatol Venereol Leprol; 2022; 88(4):464-477. PubMed ID: 34672479
[TBL] [Abstract][Full Text] [Related]
22. Target/therapies for chronic recurrent erythema nodosum leprosum.
Thangaraju P; Varthya SB; Venkatesan S
Indian J Pharmacol; 2020; 52(3):222-226. PubMed ID: 32874007
[TBL] [Abstract][Full Text] [Related]
23. Severe form of type 2 reaction in patients of Hansen's disease after withdrawal of thalidomide: case reports.
Rattan R; Shanker V; Tegta GR; Verma GK
Indian J Lepr; 2009; 81(4):199-203. PubMed ID: 20704076
[TBL] [Abstract][Full Text] [Related]
24. Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions.
Legendre DP; Muzny CA; Swiatlo E
Pharmacotherapy; 2012 Jan; 32(1):27-37. PubMed ID: 22392826
[TBL] [Abstract][Full Text] [Related]
25. Rare atypical presentations in Type 2 lepra reaction: a case series.
Vijendran P; Verma R; Vasudevan B; Mitra D; Badad A; Neema S
Int J Dermatol; 2014 Mar; 53(3):323-6. PubMed ID: 24134145
[TBL] [Abstract][Full Text] [Related]
26. Erythema nodosum leprosum: report of two cases.
Aggarwal R; Gupta O; Beg S; Prasad R
Diagn Cytopathol; 2013 Apr; 41(4):366-8. PubMed ID: 21932352
[TBL] [Abstract][Full Text] [Related]
27. Late leprosy reaction presenting as erythema multiforme-like erythema nodosum leprosum with underlying rifampicin resistance and its potential implications.
Sardana K; Kulhari A; Mathachan SR; Khurana A; Bansal P; Ahuja A; Lavania M; Ahuja M
Int J Mycobacteriol; 2020; 9(2):226-228. PubMed ID: 32474551
[TBL] [Abstract][Full Text] [Related]
28. Necrotic erythema nodosum leprosum with oral mucosal involvement.
Swain JP; Soud A; Agarwal SK
Indian J Lepr; 2008; 80(2):175-8. PubMed ID: 19425513
[TBL] [Abstract][Full Text] [Related]
29. A case of recurrent steroid-dependent severe type 2 lepra reaction treated successfully with colchicine.
Sachdeva S; Sinha S; Sardana K
Int J Mycobacteriol; 2021; 10(4):472-474. PubMed ID: 34916470
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous ulceration as a presenting feature of type 1 lepra reaction: A case report.
Hegde P; Jaiswal D; Shetty VM; Pai K; Rao R
Trop Doct; 2022 Apr; 52(2):354-356. PubMed ID: 35006027
[TBL] [Abstract][Full Text] [Related]
31. Case Report: Rapid Response to Low-Dose Thalidomide in a Case of Severe Steroid Recalcitrant Erythema Nodosum Leprosum.
Savitha B; Sardana K; Kumari R; Khurana A; Sinha S; Sachdeva S
Am J Trop Med Hyg; 2021 Oct; 106(1):51-53. PubMed ID: 34662871
[TBL] [Abstract][Full Text] [Related]
32. Elevated Pentraxin-3 Concentrations in Patients With Leprosy: Potential Biomarker of Erythema Nodosum Leprosum.
Mendes MA; de Carvalho DS; Amadeu TP; Silva BJA; Prata RBDS; da Silva CO; Ferreira H; Hacker MA; Nery JAC; Pinheiro RO; Sampaio EP; Sarno EN; Schmitz V
J Infect Dis; 2017 Dec; 216(12):1635-1643. PubMed ID: 29272525
[TBL] [Abstract][Full Text] [Related]
33. Pentoxifylline in the treatment of erythema nodosum leprosum.
De Carsalade GY; Achirafi A; Flageul B
J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
[TBL] [Abstract][Full Text] [Related]
34. [Increase in nitric oxide concentrations in serum and mononuclear cell cultures from patients with Type II reaction state of Hansen's disease].
Rada E; Marzal M; Aranzazu N; Convit J
Invest Clin; 2003 Jun; 44(2):129-36. PubMed ID: 12815843
[TBL] [Abstract][Full Text] [Related]
35. A retrospective study of the severe and uncommon variants of erythema nodosum leprosum at a tertiary health center in central India.
Wankhade VH; Debnath P; Singh RP; Sawatkar G; Bhat DM
Int J Mycobacteriol; 2019; 8(1):29-34. PubMed ID: 30860176
[TBL] [Abstract][Full Text] [Related]
36. Erythema nodosum leprosum mimicking Sweet's syndrome: an uncommon presentation.
Mahajan VK; Abhinav C; Mehta KS; Chauhan PS
Lepr Rev; 2014 Dec; 85(4):322-7. PubMed ID: 25675656
[TBL] [Abstract][Full Text] [Related]
37. Reactive perforating leprosy: pustular erythema nodosum leprosum with epidermal perforation and liberation of Mycobacterium leprae.
Ghorpade A
Int J Dermatol; 2014 Feb; 53(2):221-3. PubMed ID: 24319988
[No Abstract] [Full Text] [Related]
38. Histoid leprosy: a retrospective study of 40 cases from India.
Kaur I; Dogra S; De D; Saikia UN
Br J Dermatol; 2009 Feb; 160(2):305-10. PubMed ID: 19016704
[TBL] [Abstract][Full Text] [Related]
39. Concomitant lucio phenomenon and erythema nodosum in a leprosy patient: clues for their distinct pathogeneses.
Benard G; Sakai-Valente NY; Bianconcini Trindade MA
Am J Dermatopathol; 2009 May; 31(3):288-92. PubMed ID: 19384072
[TBL] [Abstract][Full Text] [Related]
40. Whole blood transcriptomics reveals the enrichment of neutrophil activation pathways during erythema nodosum leprosum reaction.
Rosa TLSA; Leal-Calvo T; Tavares IF; Mendes MA; Dias AA; Piauy MHDS; Barboza MFDS; Kapuscinski M; Costa FDMR; Marques MAM; Belone AFF; Sales AM; Hacker MA; Moreira MBP; Belisle JT; Moraes MO; Pessolani MCV; Schmitz V
Front Immunol; 2024; 15():1366125. PubMed ID: 38715615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
